1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Myocardial Ischemia in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (75.00) | 18.2507 |
2000's | 4 (11.11) | 29.6817 |
2010's | 5 (13.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, CD; Shi, J; Sun, HT; Tao, YK; Yu, PL; Zhang, GQ; Zhao, SP | 1 |
Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F | 1 |
Alloatti, G; Bassino, E; Penna, C | 1 |
Deev, AD; Dobrovol'skiĭ, AB; Katkova, OV; Laguta, PS; Panchenko, EP; Titaeva, EV | 1 |
Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Nomikos, T | 1 |
Alloatti, G; Hirsch, E; Lembo, G; Montrucchio, G | 1 |
Baker, KE; Curtis, MJ | 2 |
Egresits, J; Kordás, K; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I | 1 |
Chin, TK; Hofmann, PA; Leary, PJ; Morrison, RR; Rajasekaran, S; Tuomanen, EI | 1 |
Altavilla, D; Bussolino, F; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Sardella, A; Squadrito, F; Urna, G | 1 |
Barrigón, S; Fernandez-Gallardo, S; Fernandez-Sanpablo, R; Perez, MD; Salinas, P; Sanchez-Crespo, M | 1 |
Becker, BF; Raschke, P | 1 |
Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ | 1 |
Filep, JG; Földes-Filep, E; Fournier, A | 1 |
Inada, M; Iwasaka, T; Izuoka, T; Kimura, Y; Kitashiro, S; Tamura, K; Tamura, T | 1 |
Braquet, PG; Guinot, P; Hosford, D; Koltai, M | 1 |
Danchak, RM; Heim, KF; Kim, YD; Lees, DE; Myers, AK | 1 |
Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Saitta, A; Squadrito, F; Zingarelli, B | 1 |
Chen, BN; McLennan, PL; Menadue, MF; Oliver, JR; Rayner, TE | 1 |
Baudouy, M; Blanc, P; Ferrari, E; Jambou, D; Morand, P | 1 |
Alloatti, G; Cacace, G; Camussi, G; Comino, A; De Filippi, PG; Emanuelli, G; Mariano, F; Montrucchio, G; Polloni, R | 1 |
Hackett, D; O'Gorman, DJ; Shahi, M; Sheridan, DJ; Siminiak, T | 1 |
Azizova, OA; Fortinskaia, ES; Khalilov, EM; Torkhovskaia, TI; Vlasova, II | 1 |
Feuerstein, G; Leor, J; Rabinovici, R; Vonhof, S; Winkler, JD | 1 |
Ansley, DM; English, JC; Godin, DV; Kim, CW; Lee, JU; Loucks, EB; Qayumi, AK | 1 |
Bache, RJ; Kinn, JW | 1 |
Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM | 1 |
Gerritsen, ME; Granger, DN; Horie, Y; Mori, N | 1 |
Ambrosio, G; Tritto, I | 1 |
Porsius, AJ; Vleeming, W; Wemer, J | 1 |
Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
Ankri, A; Drobinski, G; Grosgogeat, Y; Maclouf, J; Mencia-Huerta, JM; Montalescot, G; Thomas, D | 1 |
Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ | 1 |
Schoonderwoerd, K; Stam, H | 1 |
Wysocki, H | 1 |
8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia
Article | Year |
---|---|
Platelet activating factor: the good and the bad in the ischemic/reperfused heart.
Topics: Humans; Ischemic Preconditioning; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor | 2011 |
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Disease Progression; Drug Design; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Ischemia; Platelet Activating Factor | 2013 |
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.
Topics: Animals; Cardiovascular System; Class Ib Phosphatidylinositol 3-Kinase; Cyclic AMP; Disease Models, Animal; Heart Diseases; Humans; Isoenzymes; Mice; Mice, Transgenic; Myocardial Ischemia; Nitric Oxide; Phenotype; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Receptors, G-Protein-Coupled; Signal Transduction | 2004 |
Platelet-activating factor antagonists: scientific background and possible clinical applications.
Topics: Animals; Antibodies, Monoclonal; Brain Ischemia; Bronchoconstriction; Humans; Inflammation; Lipopolysaccharides; Myocardial Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic | 1994 |
Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.
Topics: Animals; Cells, Cultured; Coronary Vessels; Heart; Heart Diseases; Heart Transplantation; Humans; Molecular Structure; Myocardial Contraction; Myocardial Ischemia; Myocardium; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1997 |
Reperfusion injury: experimental evidence and clinical implications.
Topics: Capillaries; Cell Adhesion Molecules; Coronary Circulation; Coronary Vessels; Free Radicals; Heart; Humans; Inflammation Mediators; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Neutrophil Activation; Neutrophils; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Reactive Oxygen Species; Thromboplastin | 1999 |
Lipid metabolism of myocardial endothelial cells.
Topics: Animals; Biological Transport; Cholesterol; Eicosanoids; Endocardium; Humans; Lipid Metabolism; Lipolysis; Lipoproteins; Membrane Lipids; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidation-Reduction; Phospholipids; Platelet Activating Factor; Triglycerides | 1992 |
The role of polymorphonuclear neutrophils in myocardial damage during ischemia and reperfusion.
Topics: Animals; Antioxidants; Capillary Resistance; Cell Adhesion; Endopeptidases; Endothelium, Vascular; Free Radicals; Humans; Hypoxanthine; Hypoxanthines; Leukotrienes; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Oxygen; Platelet Activating Factor; Platelet Aggregation; Respiratory Burst | 1992 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia
Article | Year |
---|---|
[Aspirin resistance in patients with stable ischemic heart disease].
Topics: Aged; Aspirin; Coronary Angiography; Drug Monitoring; Drug Resistance; Echocardiography, Transesophageal; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Risk Factors; Severity of Illness Index; Thromboxane B2; Treatment Outcome | 2010 |
27 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia
Article | Year |
---|---|
Elevated platelet activating factor level in ischemia-related arrhythmia and its electrophysiological effect on myocardium.
Topics: Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Swine | 2013 |
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles | 2013 |
Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antago
Topics: Animals; Azepines; Coronary Vessels; Heart Ventricles; In Vitro Techniques; Male; Myocardial Ischemia; Norepinephrine; Perfusion; Platelet Activating Factor; Potassium; Rats; Rats, Wistar; Triazoles; Ventricular Fibrillation; Ventricular Function | 2004 |
Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
Topics: Angina Pectoris; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Epinephrine; Ginkgolides; Heart Rate; Hormone Antagonists; Injections, Intravenous; Lactones; Male; Myocardial Ischemia; Ornipressin; Phentolamine; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Vasopressin; Time Factors; Vasoconstrictor Agents; Vasopressins | 2004 |
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.
Topics: Animals; Calcium; Calcium Signaling; Cell Shape; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Female; Ginkgolides; Lactones; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Platelet Activating Factor; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left | 2008 |
Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
Topics: Animals; Creatine Kinase; Disease Models, Animal; Furans; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Survival Rate | 1994 |
Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart.
Topics: Acute Disease; Animals; Chromatography, High Pressure Liquid; Diterpenes; Fibrinolytic Agents; Ginkgolides; Heart Ventricles; In Vitro Techniques; Lactones; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Platelet Activating Factor; Rabbits | 1995 |
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines | 1995 |
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine | 1994 |
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Topics: Anesthesia; Animals; Blood Pressure; Capillary Permeability; Edema; Electrocardiography; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Male; Myocardial Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Endothelin; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane A2 | 1994 |
The effects of platelet activating factor antagonist, TCV309, on the relationship between electrophysiological and mechanical status during myocardial ischemia and reperfusion.
Topics: Action Potentials; Animals; Dogs; Electrophysiology; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Pyridinium Compounds; Tetrahydroisoquinolines | 1994 |
Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
Topics: Acetylcholine; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Male; Muscle, Smooth, Vascular; Myocardial Ischemia; Platelet Activating Factor; Regional Blood Flow; Reperfusion; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation | 1993 |
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
Topics: Analysis of Variance; Animals; Biological Assay; Creatine Kinase; Isoenzymes; Leukopenia; Macrophages; Male; Myocardial Ischemia; Myocardial Reperfusion; Necrosis; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 1993 |
Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart.
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Diterpenes; Eicosanoids; Ginkgolides; Heart Rate; Lactones; Male; Masoprocol; Meclofenamic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Secretory Rate | 1993 |
[Mediators of the vascular endothelium as markers of myocardial ischemia and reperfusion].
Topics: Endothelins; Endothelium, Vascular; Epoprostenol; Humans; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Platelet Activating Factor | 1993 |
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.
Topics: Animals; Azepines; Cell Movement; Female; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Quinolines; Rabbits; Risk Factors; Triazoles | 1993 |
Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor.
Topics: Angioplasty, Balloon, Coronary; Azepines; CD18 Antigens; Cells, Cultured; Coronary Circulation; Diterpenes; Femoral Artery; Femoral Vein; Ginkgolides; Humans; Lactones; Myocardial Ischemia; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Superoxides; Triazoles | 1995 |
[Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
Topics: Adenosine Diphosphate; Fatty Acids, Unsaturated; Humans; Micelles; Myocardial Ischemia; Phosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 1996 |
The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Cardiac Output; Cardiac Volume; Disease Models, Animal; Female; Heart Arrest; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Random Allocation; Stroke Volume; Swine; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function | 1998 |
Effect of platelet activation on coronary collateral blood flow.
Topics: Animals; Blood Platelets; Collateral Circulation; Coronary Circulation; Dogs; Myocardial Ischemia; Platelet Activating Factor; Platelet Activation; Thromboxane A2; Vasoconstriction | 1998 |
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation | 1998 |
Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice.
Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Cell Adhesion; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Leukocytes; Leukotrienes; Male; Mice; Mice, Knockout; Microcirculation; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Receptors, LDL; Serum Albumin | 1999 |
Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
Topics: Animals; Anti-Arrhythmia Agents; Azepines; Disease Models, Animal; Male; Myocardial Ischemia; Perfusion; Platelet Activating Factor; Protective Agents; Rats; Rats, Wistar; Triazoles; Vasodilation; Ventricular Fibrillation | 1999 |
Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Chromatography, High Pressure Liquid; Chromones; Coronary Circulation; Heart; Histamine Release; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Platelet Activating Factor; Pressure; Rats; Rats, Wistar; Triazoles | 1992 |
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
Topics: Animals; Azepines; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Triazoles | 1992 |
Lack of platelet-activating factor release during reversible myocardial ischaemia.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Humans; Myocardial Ischemia; Platelet Activating Factor; Thromboxane B2 | 1992 |
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles | 1992 |